DSP Healthcare Fund

CAGR since inception
Scheme Type:
  • Risk:

    High Risk
  • Age:

    1 years 11 months since Nov 30, 2018
  • AUM:

    Rs. 890.49 crores as of Oct 31, 2020
  • Horizon:

    Long-term Horizon
  • Goal:

    Income Generation
  • Benchmark:

    S&P BSE HEALTHCARE (TRI)
Scheme features

Performance

Cumulative returns

Scheme disclaimers »

Returns calculator

Scheme disclaimers »

Returns summary

Rolling returns

Scheme disclaimers »

Historical Returns

In SEBI format

Scheme disclaimers »

Portfolio as of Oct 31, 2020

Equity

Market capitalization

No data to display

Sector allocation

No data to display
Top 5 stocks by holding
Name % of Net Assets
IPCA LABORATORIES LTD 9.68%
CIPLA LTD/INDIA 9.46%
DR REDDY'S LABORATORIES LTD 9.19%
DIVI'S LABORATORIES LTD 5.93%
APOLLO HOSPITALS ENTERPRISE LTD 5.01%
See detailed equity holdings »

Debt & debt instruments

Credit rating profile

No data to display

Instrument break-up

No data to display
Top instruments by holding
Name % of Net Assets
TREPS / REVERSE REPO INVESTMENTS / CORPORATE DEBT REPO 8.12%
See detailed debt holdings »

To proceed, we need to first verify your KYC status.

E.g. 01/01/1980
If you are investing as a HUF, enter Date of Incorporation of HUF that was entered in the KYC form.
×

Enter the details to proceed with Instant Redemption:

E.g. 01/01/1980
If you are redeeming as a HUF, enter Date of Incorporation of HUF that was entered in the KYC form.
×

Fast & paperless investment in 5 easy steps!

 

Verify your KYC status

 

Select your existing OR create a new folio

 

Confirm scheme & enter amount

 

Choose your payment method

 

Review order & make the payment

Online Lumpsum
Online SIP
×

To proceed, we need to first verify your KYC status.

E.g. 01/01/1980
If you are investing as a HUF, enter Date of Incorporation of HUF that was entered in the KYC form.
×

Enter the details to proceed with Instant Redemption:

E.g. 01/01/1980
If you are redeeming as a HUF, enter Date of Incorporation of HUF that was entered in the KYC form.
×
This instant KYC is an eKYC process as prescribed by regulations.
Investors understand that their principal will be at moderately low risk
Needs verification via OTP

After entering your Aadhaar number, you will be redirected to enter OTP so that we can get your Aadhaar details limited to only a few fields.


Investors understand that their principal will be at moderately low risk
eKYC has annual investment limit of ₹ 50,000

You can only invest upto ₹ 50,000 or start SIP of ₹ 4,000 to begin with. However, if your limits are breached, DSP will assist you to upgrade your KYC.

×

Complete Your KYC in 5 mins!

First-time investors need to complete a one-time KYC process to start investing. Learn More.

To begin, please enter your details in the form below.
Verify Contact Details
×

Confirm Your Details

To ensure that the details you entered are correct, please validate your email address and mobile number

Mobile Number

Didn't receive OTP?
Email Address

Didn't receive OTP?
 
Continue
DSP Mutual Fund
Do you want to receive important information and update over Whatsapp?
You will now be directed to our KYC partner, SIGNZY, to submit your documents for verification..

We are reinitiating your Ekyc flow
You will now be directed to our KYC partner, SIGNZY, to submit your documents for verification
This instant KYC is an eKYC process as prescribed by regulations.
Investors understand that their principal will be at moderately low risk
Needs verification via OTP

After entering your Aadhaar number, you will be redirected to enter OTP so that we can get your Aadhaar details limited to only a few fields.


Investors understand that their principal will be at moderately low risk
eKYC has annual investment limit of ₹ 50,000

You can only invest upto ₹ 50,000 or start SIP of ₹ 4,000 to begin with. However, if your limits are breached, DSP will assist you to upgrade your KYC.

Allow camera access.
Required for IPV (In-Person verification)

You would be asked to allow access to your camera. Please accept it, as it is mandatory to capture video to complete the application.

Address proof required.
Please Keep a valid address proof ready

You can provide Passport, Driving license, Bank passbook, Voter ID card etc as address proof.

Note: If providing Aadhar card as address proof, kindly make sure that you mask your aadhar number in the document. If Aadhar number is not masked the application can be rejected.
PAN card.
PAN card is a mandatory document for KYC.

Please keep your pan card ready, you can also use a soft copy of your PAN card for upload.

Vinit Sambre

Vinit joined DSPIM in July 2007, as Portfolio Analyst for the firm's Portfolio Management Services (PMS) division, which manages discretionary accounts and provides advisory services to institutional clients. As a research analyst, his focus was on sectors like Pharmaceuticals, Power Utilities, Chemicals, Fertilizers and Textiles. Vinit specializes in the small and mid cap space and has over 16 years of relevant work experience.
Previously, he was with DSP Merrill Lynch as a part of its Global Private Client business. He spent 20 months at DSP Merrill Lynch as Equity Strategist. Prior to DSP Merrill Lynch, he was employed with IL&FS Investsmart Limited as an Equity Analyst in their PMS division. He has also worked with UTI Investment Advisory Services as Equity Analyst for the offshore fund - India Growth Fund. Vinit is a Chartered Accountant from Institute of Chartered Accountant of India.

Note:
Gopal Agrawal managed the Schemes (i.e. DSP Top 100 Equity Fund, DSP Focus Fund, DSP Equity Savings Fund and DSP Regular Savings Fund) till May 31, 2020. Mr. Vinit Sambre is managing Schemes From June 1, 2020. (i.e. DSP Top 100 Equity Fund, DSP Focus Fund, DSP Equity Savings Fund and DSP Regular Savings Fund) with effect from June 1, 2020.

All Funds managed by Vinit Sambre
Sr. No. Period 1 Year 3 Years 5 Years

Period for which scheme's performance has been provided is computed basis last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

×

Jay Kothari

Jay Kothari, Vice President & Product Strategist -Jay has been with DSP Investment Managers since May 2005, and has been with the Investment function since January 2011. Jay joined the firm as a member of the Sales team (Banking) in May 2005. Prior to joining DSPIM, Jay worked for Standard Chartered Bank for a year in the Priority Banking division. Jay completed his Bachelor of Management Studies (Finance & International Finance) from Mumbai University, followed by an MBA in Finance from Mumbai University.
Jay is currently the Dedicated Fund Manager for overseas investments for the following schemes of DSP Mutual Fund.

All Funds managed by Jay Kothari
Sr. No. Period 1 Year 3 Years 5 Years

Period for which scheme's performance has been provided is computed basis last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

×

Asset Allocation for Healthcare Fund

×

Equity holdings for Healthcare Fund

Pharmaceuticals
71.62%

Name % of Net Assets
IPCA LABORATORIES LIMITED 9.68%
CIPLA LIMITED 9.46%
DR. REDDY'S LABORATORIES LIMITED 9.19%
DIVI'S LABORATORIES LIMITED 5.93%
PROCTER & GAMBLE HEALTH LIMITED 4.22%
TORRENT PHARMACEUTICALS LIMITED 4.09%
JB CHEMICALS & PHARMACEUTICALS LIMITED 3.74%
INTUITIVE SURGICAL INC 3.47%
SYNGENE INTERNATIONAL LIMITED 2.79%
ABBOTT LABORATORIES 2.76%
ALKEM LABORATORIES LIMITED 2.58%
JUBILANT LIFE SCIENCES LIMITED 2.52%
AARTI DRUGS LIMITED 2.49%
ALEMBIC PHARMACEUTICALS LIMITED 2.41%
INDOCO REMEDIES LIMITED 2.39%
UNICHEM LABORATORIES LIMITED 1.85%
ABBOTT INDIA LIMITED 1.09%
AJANTA PHARMA LIMITED 0.96%
78% of Equity and equity related securities

Healthcare Services
16.86%

Name % of Net Assets
APOLLO HOSPITALS ENTERPRISE LIMITED 5.01%
DR. LAL PATH LABS LTD. 3.33%
MAX HEALTHCARE INSTITUTE LIMITED 3.19%
ABIOMED INC 2.8%
NARAYANA HRUDAYALAYA LTD. 2.53%
18.4% of Equity and equity related securities

Finance
3.35%

Name % of Net Assets
ICICI LOMBARD GENERAL INSURANCE COMPANY LIMITED 3.35%
3.6% of Equity and equity related securities
×

Debt holdings for Healthcare Fund

TREPS8.12%

Name Rating % of Net Assets
TREPS / REVERSE REPO INVESTMENTS / CORPORATE DEBT REPO -- 8.12%
100% of Debt instruments
×

DSP Healthcare Fund presentation

×

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
There is no assurance that the investment objective of the Scheme will be realized

×

Why you should invest

  1. Capture the growing demand for healthcare driven by rising incomes, increasing awareness and ability to spend more on health, increased export opportunities and a positive regulatory environment
  2. Provide exposure to small & mid cap companies: These companies are poised to benefit from earnings growth and are more reasonably valued today than earlier, year to date small and mid-cap companies have corrected much more vs. large-caps in the S&P BSE Healthcare Index.
  3. Invest in leading healthcare companies from the east and the west: The fund may provide access to Indian private healthcare players with up to 25% exposure to foreign securities (currently focusing on large US healthcare companies)
  4. Benefit from our fund managers' global sector expertise with Aditya being in the sector for 13 years (worked in the US, Latin America, Europe & India) and Vinit with 21 years of fund management experience in the small/midcap space in India, including in healthcare and Jay Kothari is Dedicated Fund Manager for Overseas Investments and has 15 years of experience.
×
×